Clinical Trial Update: Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation [NA]

View source ↗

Summary

A clinical trial evaluating high-intensity statin therapy to prevent coronary artery vasculopathy after heart transplantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Vasculopathy

Drugs mentioned

• High-intensity statin therapy (statin (high-intensity))

Snippet

Sponsor: Montefiore Medical Center | Conditions: Vasculopathy | NA | Status: WITHDRAWN